Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES)

Activity: Talk or presentationOral presentation

Description

29 May 2020

Event (Conference)

TitleASCO annual meeting
Period29/05/2031/05/20
Location
City